Media coverage about Cerner (NASDAQ:CERN) has trended somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cerner earned a media sentiment score of 0.21 on Accern’s scale. Accern also assigned news stories about the company an impact score of 46.1624037942877 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

These are some of the news stories that may have impacted Accern Sentiment Analysis’s analysis:

Shares of Cerner (NASDAQ:CERN) opened at $68.50 on Monday. The company has a quick ratio of 2.75, a current ratio of 2.77 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $22,803.66, a P/E ratio of 34.01, a P/E/G ratio of 2.04 and a beta of 0.94. Cerner has a twelve month low of $51.26 and a twelve month high of $73.86.

Cerner (NASDAQ:CERN) last posted its earnings results on Thursday, October 26th. The company reported $0.61 earnings per share for the quarter, missing analysts’ consensus estimates of $0.62 by ($0.01). The company had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.29 billion. Cerner had a return on equity of 18.03% and a net margin of 13.37%. The firm’s quarterly revenue was up 7.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.59 EPS. research analysts expect that Cerner will post 2.24 EPS for the current fiscal year.

Several analysts recently commented on CERN shares. Royal Bank of Canada reaffirmed a “buy” rating on shares of Cerner in a report on Wednesday, October 25th. SunTrust Banks reiterated a “buy” rating and set a $79.00 target price on shares of Cerner in a research report on Thursday, October 19th. Zacks Investment Research upgraded Cerner from a “hold” rating to a “buy” rating and set a $81.00 target price on the stock in a research report on Tuesday, October 17th. Jefferies Group set a $79.00 price objective on Cerner and gave the company a “buy” rating in a research report on Friday, October 13th. Finally, Piper Jaffray Companies restated a “buy” rating and issued a $77.00 price objective on shares of Cerner in a research report on Thursday, October 12th. One research analyst has rated the stock with a sell rating, sixteen have issued a hold rating and eight have issued a buy rating to the stock. Cerner presently has a consensus rating of “Hold” and an average price target of $70.21.

In other news, Chairman Clifford W. Illig sold 4,000 shares of the stock in a transaction on Tuesday, November 7th. The stock was sold at an average price of $65.96, for a total transaction of $263,840.00. Following the completion of the sale, the chairman now owns 1,229,719 shares in the company, valued at approximately $81,112,265.24. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Chairman Clifford W. Illig sold 530,000 shares of the stock in a transaction on Monday, November 20th. The shares were sold at an average price of $65.54, for a total value of $34,736,200.00. Following the sale, the chairman now owns 1,229,719 shares of the company’s stock, valued at approximately $80,595,783.26. The disclosure for this sale can be found here. In the last quarter, insiders have sold 788,000 shares of company stock valued at $52,190,800. Company insiders own 13.11% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This report was published by Marea Informative and is the sole property of of Marea Informative. If you are accessing this report on another site, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this report can be viewed at

About Cerner

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

Insider Buying and Selling by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with's FREE daily email newsletter.